Biden prostate cancer described as “aggressive” what to know about the prognosis of the disease

Prostate cancer cases have increased in recent years, increasing 3% per year since 2014, and now former President Joe Biden is one of the more than 300,000 men who are diagnosed this year.

The Biden office published the announcement on Sunday, days after the news that a “small nodule” had been found in the former president’s prostate during a routine exam.

“While this represents a more aggressive form of the disease, cancer seems to be sensitive to hormones, allowing effective management,” said his office. “The president and his family are reviewing the treatment options with their doctors.”

The new prostate cancer test indicates the disease better than the PSA option, the study finds

The treatment is usually more effective when prostate cancer is sensitive to hormones, since that means that the disease will probably respond better to hormonal therapy, according to Mayo Clinic.

Hormonal therapy is used to block the effects of hormones that feed the growth of prostate cancer cells.

“Prostate cancer cells depend on testosterone to help them grow. Cutting the testosterone supply can cause cancer cells to die or grow more slowly,” said the previous source.

In addition to hormonal therapy, common treatment options for prostate cancer include chemotherapy, directed therapy, immunotherapy and radiopharmaceutical treatments.

What to know about prostate cancer

Prostate cancer It is a disease found in men that develops in the prostate gland.

According to the American Society of American Society Cancer, and 35,770 men will die of 313,780 new cases of prostate cancer, and 35,770 men will die from the disease, according to the American Cancer Society.

Hormonal therapy is used to block the effects of hormones that feed the growth of prostate cancer cells.

One in eight men will be diagnosed with prostate cancer in his life, he declared the same source.

Older men have a higher risk of disease, with six out of 10 cases diagnosed in patients with 65 years or more. The average age in the diagnosis is 67, with men under 40 rarely affected. Biden has 82.

Prostate cancer medication now available for more patients with an aggressive manner

Prostate cancer is the second most common cancer in men, just behind skin cancerACS said.

Signs and symptoms

Among men who undergo routine prostate cancer detection, the disease is usually captured early before symptoms arise, according to ACS.

Typical early symptoms include urinating problems, a weak or slow urinary current or a greater need to urinate.

Some men may also notice blood in the urine or body fluids.

More advanced symptoms can occur after the disease has spread. Those may include hips pain, back (column), chest (ribs) or other areas, according to ACS.

Click here to register in our health newsletter

Men can also suffer erectile dysfunction, weight loss, extreme fatigue, weakness in the legs or feet, or loss of bladder or intestinal control.

Detection recommendations

The US Preventive Services Task Force. UU. It states that men aged 55 to 69 must have the option of undergoing periodic detection based on prostate antigen (PSA) to monitor prostate cancer.

“Before deciding whether to be evaluated, men should have the opportunity to discuss the possible benefits and damage of detection with their clinician and incorporate their values ​​and preferences in the decision,” says the USPSTF.

While detection offers a “small potential benefit” to reduce the possibilities of dying of the disease, the agency said that some men may experience negative effects, including false positive results, overdiagnosis and over -treatment and treatment complications.

Click here to get the News application

Currently, alternative prostate cancer detection methods are being investigated, including one that uses a non -invasive urine test, as News Digital recently reported.

Survival rates

For localized prostate cancers, where the disease is contained within the prostate, the five -year survival rate is at least 99%, according to ACS.

For regional cases, where the disease has extended only to “nearby structures or lymph nodes”, the five -year survival rate is also 99% or more.

If cancer has spread to other areas of the body, the five -year survival rate decreases to 37%.

For more health articles, visit www.Newsnews.com/health

Royal survival rates may vary according to the patient’s age, general health, how cancer has progressed after diagnosis, the response of the disease to treatment and other factors, ACS said.